Literature DB >> 34246341

WHO COVID-19 therapeutic guidelines.

Bram Rochwerg1, Thomas Agoritsas2, Janet Diaz3, Lisa Askie4.   

Abstract

Entities:  

Year:  2021        PMID： 34246341      PMCID： PMC8266290          DOI： 10.1016/S0140-6736(21)01331-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.

Authors:  Stefan Schandelmaier; Matthias Briel; Ravi Varadhan; Christopher H Schmid; Niveditha Devasenapathy; Rodney A Hayward; Joel Gagnier; Michael Borenstein; Geert J M G van der Heijden; Issa J Dahabreh; Xin Sun; Willi Sauerbrei; Michael Walsh; John P A Ioannidis; Lehana Thabane; Gordon H Guyatt
Journal:  CMAJ       Date:  2020-08-10       Impact factor: 8.262

2.  Guidelines should not pool evidence from uncomplicated and severe COVID-19.

Authors:  Nicholas J White; Nathalie Strub-Wourgaft; Abul Faiz; Philippe J Guerin
Journal:  Lancet       Date:  2021-03-23       Impact factor: 79.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.